BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4387360)

  • 1. Inhibition of folate biosynthesis and function as a basis for chemotherapy.
    Hitchings GH; Burchall JJ
    Adv Enzymol Relat Areas Mol Biol; 1965; 27():417-68. PubMed ID: 4387360
    [No Abstract]   [Full Text] [Related]  

  • 2. The biosynthesis of pteridines.
    Brown GM
    Adv Enzymol Relat Areas Mol Biol; 1971; 35():35-77. PubMed ID: 4361155
    [No Abstract]   [Full Text] [Related]  

  • 3. The synthesis of p-aminobenzoic acid and folic acid by staphylococci sensitive and resistant to sulphonamides.
    White PJ; Woods DD
    J Gen Microbiol; 1965 Aug; 40(2):243-53. PubMed ID: 5867757
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim, a sulphonamide potentiator.
    Bushby SR; Hitchings GH
    Br J Pharmacol Chemother; 1968 May; 33(1):72-90. PubMed ID: 5301731
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfonamide structure-activity relationship in a cell-free system. Correlation of inhibition of folate synthesis with antibacterial activity and physicochemical parameters.
    Miller GH; Doukas PH; Seydel JK
    J Med Chem; 1972 Jul; 15(7):700-6. PubMed ID: 4557856
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition by pyrimidine analogues of the synthesis of folic acid by trachoma agents.
    Reeve P; Taverne J; Bushby SR
    J Hyg (Lond); 1968 Jun; 66(2):295-306. PubMed ID: 5304542
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbial synthesis of folate polyglutamates from labelled precursors.
    Brown JP; Dobbs F; Davidson GE; Scott JM
    J Gen Microbiol; 1974 Sep; 84(1):163-72. PubMed ID: 4215862
    [No Abstract]   [Full Text] [Related]  

  • 8. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection of microbial dihydrofolate reductase against inactivation by pronase.
    Burchall J
    Mol Pharmacol; 1968 May; 4(3):238-46. PubMed ID: 4385611
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide-containing folate analog.
    Bock L; Miller GH; Schaper KJ; Seydel JK
    J Med Chem; 1974 Jan; 17(1):23-8. PubMed ID: 4357096
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues.
    Stone SR; Morrison JF
    Biochim Biophys Acta; 1986 Feb; 869(3):275-85. PubMed ID: 3511964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli.
    Seydel JK; Wempe E; Miller GH; Miller L
    Chemotherapy; 1972; 17(4):217-58. PubMed ID: 4557279
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the effectiveness with which p-aminobenzoic acid and p-aminobenzoylglutamic acid are used as substrate by dihydropteroate synthetase from Escherichia coli.
    Richey DP; Brown GM
    Biochim Biophys Acta; 1970 Oct; 222(1):237-9. PubMed ID: 4919883
    [No Abstract]   [Full Text] [Related]  

  • 14. The combined action of pyrimidines and sulfonamides or sulfones in the chemotherapy of malaria and other protozoal infections.
    Richards WH
    Adv Pharmacol Chemother; 1970; 8():121-47. PubMed ID: 5002795
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
    Seydel JK; Richter M; Wempe E
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors.
    McCormick GJ; Canfield CJ; Willet GP
    Exp Parasitol; 1971 Aug; 30(1):88-93. PubMed ID: 5316583
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydrofolate reductase inhibitors as antimicrobial agents and their potentiation by sulfonamides.
    Rollo IM
    CRC Crit Rev Clin Lab Sci; 1970 Dec; 1(4):565-83. PubMed ID: 4942542
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-(1-Adamantyl) pyrimidines as inhibitors of folate metabolism.
    Ho YK; Hakala MT; Zakrzewski SF
    Cancer Res; 1972 May; 32(5):1023-8. PubMed ID: 4552913
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of thymidylate synthetase from dichloromethotrexate-resistant Lactobacillus casei.
    Crusberg TC; Leary R; Kisliuk RL
    J Biol Chem; 1970 Oct; 245(20):5292-6. PubMed ID: 4918842
    [No Abstract]   [Full Text] [Related]  

  • 20. R factors conferring resistance to trimethoprim but not sulphonamides.
    Hedges RW; Datta N; Fleming MP
    J Gen Microbiol; 1972 Dec; 73(3):573-5. PubMed ID: 4571517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.